Skip to main content
Top

Clinical & Experimental Metastasis

Issue 1/1999

Content (14 Articles)

Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors

Hugues Malonne, Ingrid Langer, Robert Kiss, Ghanem Atassi

Delay in administration of CDDP until completion of AGM-1470 treatment enhances antimetastatic and antitumor effects

Toru Morishita, Yoshizumi Miyauchi, Yoshio Mii, Shuichi Miura, Kanya Honoki, Makoto Aoki, Akira Kido, Masatoshi Yoshimoto, Susumu Tamai, Masahiro Tsutsumi, Yoichi Konishi

Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

Pablo Matar, Viviana R. Rozados, M. Mercedes Binda, Eduardo A. Roggero, R. Daniel Bonfil, O. Graciela Scharovsky

Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice

Masaaki Iigo, Tetsuya Kuhara, Yoshihiko Ushida, Kazunori Sekine, Malcolm A. Moore, Hiroyuki Tsuda

An ultra-metastatic model of human colon cancer in nude mice

Fang X. Sun, Aaron R. Sasson, Ping Jiang, Zili An, Reza Gamagami, Lingna Li, A.R. Moossa, Robert M. Hoffman

Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12

David P. Shrayer, Bernard Cole, Vincent J. Hearing, Stanley F. Wolf, Harold J. Wanebo

CD44 expression and hyaluronic acid binding of malignant glioma cells

M.M. Knüpfer, H. Poppenborg, M. Hotfilder, K. Kühnel, J.E.A. Wolff, M. Domula

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine